Predictors of remission and recovery in a first-episode schizophrenia spectrum disorder sample: 2-Year follow-up of the OPUS trial

Canadian Journal of Psychiatry

Volumn 53, Issue 10, 2008, Pages 660-670

  Petersen, Lone ^a,b   Thorup, Anne ^a   Øqhlenschlæger, Johan ^c   Christensen, Torben Øqstergaard ^d   Jeppesen, Pia ^a   Krarup, Gertrud ^d   Jørrgensen, Per ^d   Mortensen, Erik Lykke ^e   Nordentoft, Merete ^a  

^a BISPEBJERG HOSPITAL   (Denmark)

^b Psychiatric Centre Ballerup   (Denmark)

^c Sct Hans Hospital   (Denmark)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Cohort; Epidemiology; Longitudinal; Psychosis; Schizophrenia

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONVALESCENCE; DEMOGRAPHY; DISEASE DURATION; FAMILY THERAPY; FEMALE; FOLLOW UP; GROUP THERAPY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH SERVICE; NEGATIVE SYNDROME; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PREDICTOR VARIABLE; PSYCHIATRIC DIAGNOSIS; PSYCHOEDUCATION; PSYCHOSIS; REMISSION; SCHIZOPHRENIA; SOCIAL ADAPTATION; SOCIAL PSYCHOLOGY; SUBSTANCE ABUSE; TREATMENT OUTCOME;

EID: 55449086238     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674370805301005     Document Type: Article

References (42)

1. McGlashan TH , Carpenter WT Jr. Long-term follow up studies of schizophrenia: editors' introduction. Schizophr Bull. 1988;14:497-500.
2. Larsen TK, Moe LC, Vibe-Hansen L, et al. Premorbid functioning versus duration of untreated psychosis in 1 year outcome in first-episode psychosis. Schizophr Res. 2000;45:1-9.
3. Melle I, Larsen TK, Haahr U, et al. Reducing the duration of untreated first-episode psychosis: effects on clinical presentation. Arch Gen Psychiatry. 2004;61:143-150.
4. Addington J, Van Mastrigt S, Addington D. Duration of untreated psychosis: impact on 2-years outcome. Psychol Med. 2004;34:277-284.
5. Malla A, Norman R, Manchanda R, et al. One year outcome in first episode psychosis: influence of DUP and other predictors. Schizophr Res. 2002;54:231-242.
6. Marshall M, Lewis S, Lockwood A, et al. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry. 2005;62:975-983.
7. Leung A, Chue P. Sex differences in schizophrenia, a review of the literature. Acta Psychiatr Scand Suppl. 2000;101:3-38.
8. Thorup A, Waltoft BL, Pedersen CB, et al. Young males have a higher risk of developing schizophrenia: a Danish register study. Psychol Med. 2007;37:479-484.
9. Tamminga C A, Buchanan RW, Gold JM. The role of negative symptoms and cognitive dysfunction in schizophrenia outcome. Int Clin Psychopharmacol. 1998;13:S21-S26.
10. Ho BC, Nopoulos P, Flaum M, et al. Two-year outcome in first-episode schizophrenia: predictive value of symptoms for quality of life. Am J Psychiatry. 1998;155:1196-1201.
11. Malla A, Norman R, Takhar J, et al. Can patients at risk for persistent negative symptoms be identified during their first episode of psychosis? J Nerv Ment Dis. 2004;192:455-463.
12. Bailer J, Baruer W, Rey ER. Premorbid adjustment as predictor of outcome in schizophrenia: results of a prospective study. Acta Psychiatr Scand. 1996;93:368-377.
13. Addington J, Van Mastrigt S, Addington D. Patterns of premorbid functioning in first-episode psychosis: initial presentation. Schizophr Res. 2003;62:23-30.
14. Ascher-Svanum H, Faries DE, Zhu B, et al. Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. J Clin Psychiatry. 2006;67:453-460.
15. Wade D, Harrigan S, Edwards J, et al. Substance misuse in first-episode psychosis: 15-month prospective follow-up study. Br J Psychiatry. 2006;189:229-234.
16. Dixon, LB. Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes. Schizophr Res. 1999;35:93-100.
17. Dixon LB. Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden. Schizophr Res. 2001;48:69-82.
18. Petersen L, Jeppesen P, Thorup A, et al. The OPUS trial: a randomised multi-centre trial of integrated versus standard treatment for 547 first-episode psychotic patients. BMJ. 2005;331:602.
19. World Health Organization. Classification of mental and behavioral disorders: diagnostic criteria for research. Geneva (CH): WHO; 1993.
20. Division of Mental Health. Present State Examination World Health Organization. Schedule for Clinical Assessment in Neuropsychiatry, version 2.1. Geneva (CH): WHO; 1998.
21. Andreasen N. Schedule for Assessment of Negative Symptoms. Iowa City (IA): The University of Iowa; 1983.
22. Andreasen N, Flaum M, Swayze VW, et al. Positive and negative symptoms in schizophrenia. A critical appraisal. Arch Gen Psychiatry. 1990;47:615-621.
23. Andreasen N. Schedule for Assessment of Positive Symptoms. Iowa City (IA): The University of Iowa; 1984.
24. Jones SH, Thornicroft G, Coffey M, et al. A brief mental health outcome scale - reliability and validity of the Global Assessment of Functioning (GAF). Br J Psychiatry. 1995;166:654-659.
25. Endicott J, Spitzer RL, Fleiss JL, et al. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry. 1976;33:766-771.
26. Häfner H, Riecher-Rossler A, Hambrecht M, et al. (1992) IRAOS: an instrument for the assessment of onset and early course of schizophrenia. Schizophrenia Res. 1992;6:209-223.
27. Cannoon-Spoor HE, Potkin SG, Wyatt RJ. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull. 1982;8:470-484.
28. Van Mastrigt S, Addington J. Assessment of premorbid function in first-episode schizophrenia: modifications to the Premorbid Adjustment Scale. J Psychiatry Neuro. 2002;27:92-101.
29. Larsen TK, Friis S, Haahr U, et al. Premorbid adjustment in first-episode non-affective psychosis: distinct patterns of pre-onset course. Br J Psychiatry. 2004;185:108-115.
30. Andreasen NC, Carpenter WT Jr, Kane JM, et al. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry. 2005;162:441-449.
31. Carpenter WT Jr, Strauss JS. The prediction of outcome in schizophrenia IV: eleven-year follow-up of the Washington IPSS cohort. J Nerv Ment Dis. 1991;179:517-525.
32. Strauss J, Carpenter WT Jr. The prediction of outcome in schizophrenia. Arch Gen Psychiatry. 1974;31:37-42.
33. Menezes NM, Arenovich T, Zipursky RB. A systematic review of longitudinal outcome studies of first-episode psychosis. Psychol Med. 2006;36:1349-1362.
34. Liberman RP, Kopelowicz A. Recovery from schizophrenia: a concept in search of research. Psychiatr Serv. 2005;56:735-742.
35. Strauss JS, Carpenter WT Jr. Prediction of outcome in schizophrenia. III. Five-year outcome and its predictors. Arch Gen Psychiatry. 1977;34:159-163.
36. Lenior ME, Dingemans PM, Schene AH, et al. Predictors of the early 5-year course of schizophrenia: a path analysis. Schizophr Bull. 2005;31:781-791.
37. Altamura AC, Bassetti R, Sassella F, et al. (2001) Duration of untreated psychosis as a predictor of outcome in first-episode schizophrenia: a retrospective study. Schizophrenia Res. 2006;52:29-36.
38. Malla A, Norman R, Schmitz N, et al. Predictors of rate and time to remission in first-episode psychosis: a two-year outcome study. Psychol Med. 2006;36:649-658.
39. Buhler B, Hambrecht M, Loffler W, et al. Precipitation and determination of the onset and course of schizophrenia by substance abuse - a retrospective and prospective study of 232 population-based first illness episodes. Schizophr Res. 2002;54:243-251.
40. Thorup A, Petersen L, Jeppesen P, et al. Integrated treatment ameliorates negative symptoms in first episode psychosis - results from the Danish OPUS trial. Schizophr Res. 2005;79:95-105.
41. Marwaha S, Johnson S. Schizophrenia and employment. A review. Soc Psychiatry Psychiatr Epidemiol. 2004;39:337-349.
42. Robinson DG, Woerner M, McMeniman M, et al. Symptomatic and functional recovery from first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry. 2004;161:473-479.